STERIS (STE) Stock Forecast & Price Target

$222.53 +2.51 (+1.14%)

Closing price 04/17/2025 03:59 PM Eastern

Extended Trading

$222.28 -0.24 (-0.11%)

As of 04/17/2025 04:33 PM Eastern

STERIS - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 5 Analyst Ratings

Sell
0

Hold
1

Buy
4

Based on 5 Wall Street analysts who have issued ratings for STERIS in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 5 analysts, 1 has given a hold rating, and 4 have given a buy rating for STE.

Consensus Price Target

$258.75
16.28% Upside

According to the 5 analysts' twelve-month price targets for STERIS, the average price target is $258.75. The highest price target for STE is $265.00, while the lowest price target for STE is $240.00. The average price target represents a forecasted upside of 16.28% from the current price of $222.53.

Get the Latest News and Ratings for STE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for STERIS and its competitors.

STE Analyst Ratings Over Time

Type	Current Forecast 4/20/24 to 4/20/25	1 Month Ago 3/21/24 to 3/21/25	3 Months Ago 1/21/24 to 1/20/25	1 Year Ago 4/21/23 to 4/20/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$258.75	$258.75	$262.50	$239.60
Forecasted Upside	16.28% Upside	17.43% Upside	25.30% Upside	20.09% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

STE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

STE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

STERIS Stock vs. The Competition

Type	STERIS	Medical Companies	S&P 500
Consensus Rating Score	2.80	2.81	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	16.28% Upside	21,675.79% Upside	26.48% Upside
News Sentiment Rating	Very Positive News See Recent STE News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/10/2025	JMP Securities 2 of 5 stars	David Turkaly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$265.00 ➝ $265.00	+20.94%
4/7/2025	Needham & Company LLC 2 of 5 stars	Mike Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
2/6/2025	Stephens 4 of 5 stars	Jacob Johnson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$240.00 ➝ $240.00	+7.49%
2/3/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Bednar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$260.00 ➝ $265.00	+21.26%
9/3/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$255.00 ➝ $265.00	+9.11%
12/4/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$225.00 ➝ $215.00	+5.65%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 11:22 AM ET.

Should I Buy STERIS Stock? STE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, April 15, 2025. Please send any questions or comments about these STERIS pros and cons to contact@marketbeat.com.

STERIS
Bull Case

Here are some ways that investors could benefit from investing in STERIS plc:

STERIS plc has a strong market capitalization of $21.73 billion, indicating a solid position in the medical equipment industry, which can provide stability and growth potential for investors.
The company reported a return on equity of 13.91%, showcasing its ability to generate profit from shareholders' equity, which is a positive indicator of financial health.
With a current stock price of $221.18, STERIS plc is trading near its 50-day moving average of $222.61, suggesting that the stock is performing consistently and may be a good entry point for investors.
STERIS plc has a low debt-to-equity ratio of 0.32, indicating that the company is not heavily reliant on debt to finance its operations, which reduces financial risk for investors.
The company has a dividend yield of 1.03% with a recent quarterly dividend of $0.57, providing a steady income stream for investors looking for dividend-paying stocks.

STERIS
Bear Case

Investors should be bearish about investing in STERIS plc for these reasons:

The stock has a high price-to-earnings (PE) ratio of 46.96, which may indicate that the stock is overvalued compared to its earnings, potentially leading to a price correction.
Recent earnings results showed that STERIS plc missed analysts' consensus estimates by $0.01, which could raise concerns about the company's ability to meet future earnings expectations.
Despite a strong market position, the company has a net margin of 8.66%, which may be considered low in the industry, suggesting that profit generation could be a challenge.
With a beta of 0.87, the stock is less volatile than the market, which may limit potential gains during bullish market conditions, making it less attractive for aggressive investors.
Analysts have mixed ratings on the stock, with only one hold rating and five buy ratings, indicating uncertainty in the market about the stock's future performance.

STE Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for STERIS is $258.75, with a high forecast of $265.00 and a low forecast of $240.00.
: 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There is currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" STE shares.
: According to analysts, STERIS's stock has a predicted upside of 16.28% based on their 12-month stock forecasts.
: STERIS has been rated by research analysts at JMP Securities, Needham & Company LLC, Piper Sandler, and Stephens in the past 90 days.
: Analysts like STERIS less than other "medical" companies. The consensus rating score for STERIS is 2.80 while the average consensus rating score for "medical" companies is 2.81. Learn more on how STE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:STE) was last updated on 4/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STERIS (STE) Stock Forecast & Price Target